FDA Approves Unknown Drug — GRAVITI PHARMS

# FDA Approves Generic Drug Application for Graviti Pharms Graviti Pharms has received FDA approval for ANDA201380, marking the company's entry into the generic pharmaceutical market and positioning it to capture market share from existing brand-name competitors. The approval expands Graviti's product portfolio and provides opportunities for revenue growth through competitive generic pricing.